CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 77 filers reported holding CHEMOCENTRYX INC in Q2 2016. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $42,000 | -2.3% | 4,504 | -24.3% | 0.04% | +8.3% |
| Q1 2017 | $43,000 | -82.0% | 5,949 | -81.6% | 0.04% | -63.3% |
| Q4 2016 | $239,000 | +27.8% | 32,289 | +4.0% | 0.10% | -21.0% |
| Q3 2016 | $187,000 | +289.6% | 31,040 | +192.9% | 0.12% | +244.4% |
| Q2 2016 | $48,000 | – | 10,599 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
| Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
| Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
| WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
| Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
| A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
| BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |